Sectors
ADCT
ADC Therapeutics SA
1.17
3500 x 1.17
2900 x 1.20
bid
ask
+
0.03
2.63%
3200 @ 07:47 PM
1.17 +0.00 (0.00%)
| Ytd | -66.86% | |
| 1y | -61.89% |
1.13
day range
1.19
0.78
52 week range
4.98
| Open | 1.13 | Prev Close | 1.14 | Low | 1.13 | High | 1.19 | Mkt Cap | 149.37M |
| Vol | 1.25M | Avg Vol | 2.01M | EPS | -0.60 | P/E | N/A | Forward P/E | -1.36 |
| Beta | 1.60 | Short Ratio | 6.98 | Inst. Own | 61.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 1.14 | 200-d Avg | 3.03 | 1yr Est | 8.40 |
| Income Statement | |||
| Total Revenue | 19.25M | ||
| Revenues (USD) | 19.25M | ||
| Cost of Revenue | 2.35M | ||
| Gross Profit | 16.90M | ||
| Operating Expenses | 42.31M | ||
| Research and Development Expense | 17.37M | ||
| Selling, General and Administrative Expense | 22.27M | ||
| Operating Income | -25.41M | ||
| Interest Expense | 13.51M | ||
| Net Income | -16.57M | ||
| Net Income Common Stock | -16.57M | ||
| Net Income Common Stock (USD) | -16.57M | ||
| Consolidated Income | -16.57M | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -3.06M | ||
| Earning Before Interest & Taxes (USD) | -3.06M | ||
| Weighted Average Shares | 155.02M | ||
| Weighted Average Shares Diluted | 155.02M | ||
| Balance Sheet | |||
| Cash and Equivalents | 219.11M | ||
| Cash and Equivalents (USD) | 219.11M | ||
| Trade and Non-Trade Receivables | 28.04M | ||
| Current Assets | 261.71M | ||
| Property, Plant & Equipment Net | 1.10M | ||
| Total Assets | 279.38M | ||
| Debt Current | 6.18M | ||
| Total Debt | 117.56M | ||
| Current Liabilities | 86.33M | ||
| Debt Non-Current | 111.38M | ||
| Total Liabilities | 507.58M | ||
| Accumulated Retained Earnings (Deficit) | -1.69B | ||
| Accumulated Other Comprehensive Income | -814.00K | ||
| Shareholders Equity | -228.20M | ||
| Shareholders Equity (USD) | -228.20M | ||
| Assets Non-Current | 17.67M | ||
| Total Debt (USD) | 117.56M | ||
| Inventory | 20.26M | ||
| Liabilities Non-Current | 421.25M | ||
| Trade and Non-Trade Payables | 12.76M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | -114.00K | ||
| Net Cash Flow from Financing | -99.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.91M | ||
| Issuance (Purchase) of Equity Shares | 118.00K | ||
| Net Cash Flow from Operations | -11.81M | ||
| Effect of Exchange Rate Changes on Cash | 5.00K | ||
| Share Based Compensation | 4.55M | ||